XenoLight RediJect 2-DeoxyGlucosone (DG) 750 is a fluorescent imaging probe for in vivo targeting of tumors that typically exhibit elevated glucose uptake rate in comparison to surrounding tissues. To achieve maximum glucose targeting and enhanced tumor uptake, the probe has been designed to contain four 2-DG molecules per dye molecule.
Please enter valid quantity
Please login to add favorites
NULL OR EMPTY CART
|Product Number||List Price||Your Price||Quantity|
You successfully added item(s) to your cart
RediJect 2-DG fluorescent imaging probe Standard Kit:
For laboratory use only. This product is intended for animal research only and not for use in humans.
Disclaimer: For laboratory use only. This product is intended for animal research only and not for use in humans.
|Fluorescent Agent Type||Targeted|
|Optical Imaging Classification||Fluorescence Imaging|
|Product Brand Name||XenoLight|
|Quantity in a Package Amount||20.0 Units|
|Shipping Condition||Blue Ice|
|Therapeutic Area||Oncology/Cancer, Arthritis, Inflammation|
|Unit Size||1 Kit (20 animals)|
|Wave Length||750 nm|
|Resource Type||File Name||File Format|
|Brochure||In Vivo Imaging Agents Brochure||PDF 2 MB|
|Brochure||XenoLight RediJect 2-DG-750 Probe (Product Sheet)||PDF 985 KB|
|Data Sheet||Material Safety Data Sheet||PDF 100 KB|
|Citations Library||View peer reviewed publications using PerkinElmer's In Vivo Imaging Reagents||Link|
|Webinar||View our complete list of in vivo webinars available on demand||Link|